The American Journal of Medicine
Volume 122, Issue 6 , Pages 582.e1-582.e9 , June 2009

C-Reactive Protein Elicits White Blood Cell Activation in Humans

  • Radjesh J. Bisoendial, MD, PhD

      Affiliations

    • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationRequests for reprints should be addressed to Radjesh J. Bisoendial, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, Meibergdreef 9, Room F4-222, 1105 AZ Amsterdam, The Netherlands
    • ,
  • Rakesh S. Birjmohun, MD

      Affiliations

    • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Fatima Akdim, MD

      Affiliations

    • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Cornelis van ‘t Veer, PhD

      Affiliations

    • Department of Experimental Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • C. Arnold Spek, PhD

      Affiliations

    • Department of Experimental Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Daniel Hartman, MD, PhD

      Affiliations

    • deCODE genetics, Reykjavik, Iceland
    • ,
  • Els R. de Groot

      Affiliations

    • Department of Immunopathology, Sanguin Research, Amsterdam, The Netherlands
    • ,
  • Danute M. Bankaitis-Davis, PhD

      Affiliations

    • Source Molecular Diagnostics, Boulder, Colorado
    • ,
  • John J.P. Kastelein, MD, PhD

      Affiliations

    • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • Erik S.G. Stroes, MD, PhD

      Affiliations

    • Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands

References 

  1. Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611–2618
  2. Meier CR, Jick SS, Derby LE, et al. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet. 1998;351:1467–1471
  3. Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction. BMJ. 1989;298:779–781
  4. Maier W, Altwegg LA, Corti R, et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid a but decreased C-reactive protein. Circulation. 2005;111:1355–1361
  5. Brennan ML, Penn MS, Van LF, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med. 2003;349:1595–1604
  6. Grau AJ, Boddy AW, Dukovic DA, et al. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke. 2004;35:1147–1152
  7. Cao JJ, Thach C, Manolio TA, et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation. 2003;108:166–170
  8. Venugopal SK, Devaraj S, Yuhanna I, et al. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002;106:1439–1441
  9. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis?. Hypertension. 2004;44:6–11
  10. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165–2168
  11. Bisoendial RJ, Kastelein JJ, Levels JH, et al. Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res. 2005;96:714–716
  12. Rainen L, Oelmueller U, Jurgensen S, et al. Stabilization of mRNA expression in whole blood samples. Clin Chem. 2002;48:1883–1890
  13. Wettinger SB, Doggen CJ, Spek CA, et al. High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells. Blood. 2005;105:2000–2006
  14. Taylor KE, Giddings JC, van den Berg CW. C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arterioscler Thromb Vasc Biol. 2005;25:1225–1230
  15. van Deventer SJ, Buller HR, ten Cate JW, et al. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood. 1990;76:2520–2526
  16. Shah PK, Galis ZS. Matrix metalloproteinase hypothesis of plaque rupture: players keep piling up but questions remain. Circulation. 2001;104:1878–1880
  17. Papaspyridonos M, Smith A, Burnand KG, et al. Novel candidate genes in unstable areas of human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2006;26:1837–1844
  18. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest. 1991;88:1121–1127
  19. Gu L, Okada Y, Clinton SK, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell. 1998;2:275–281
  20. Inoue S, Egashira K, Ni W, et al. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation. 2002;106:2700–2706
  21. Rhee JS, Santoso S, Herrmann M, et al. New aspects of integrin-mediated leukocyte adhesion in inflammation: regulation by haemostatic factors and bacterial products. Curr Mol Med. 2003;3:387–392
  22. Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol. 2002;3:932–943
  23. Wolpe SD, Cerami A. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J. 1989;3:2565–2573
  24. Abe N, Osanai T, Fujiwara T, et al. C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: inhibitory effect of fluvastatin. Life Sci. 2006;78:1021–1028
  25. Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation. 2002;105:1890–1896
  26. Bharadwaj D, Stein MP, Volzer M, et al. The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med. 1999;190:585–590
  27. Mineo C, Gormley AK, Yuhanna IS, et al. Fc{gamma}RIIB mediates C-reactive protein inhibition of endothelial NO synthase. Circ Res. 2005;97:1124–1131Epub 2005 Nov
  28. Devaraj S, Du Clos TW, Jialal I. Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol. 2005;25:1359–1363
  29. Lim MY, Wang H, Kapoun AM, et al. p38 Inhibition attenuates the pro-inflammatory response to C-reactive protein by human peripheral blood mononuclear cells. J Mol Cell Cardiol. 2004;37:1111–1114
  30. Lin R, Liu J, Peng N, et al. Lovastatin reduces nuclear factor kappaB activation induced by C-reactive protein in human vascular endothelial cells. Biol Pharm Bull. 2005;28:1630–1634
  31. Devaraj S, Davis B, Simon SI, Jialal I. CRP promotes monocyte-endothelial cell adhesion via Fc gamma receptors in human aortic endothelial cells under static and shear flow conditions. Am J Physiol Heart Circ Physiol. 2006;291:H1170–H1176Epub 2006 Apr 7
  32. Agrawal A, Agrawal S, Cao JN, et al. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol. 2007;178:6912–6922
  33. Bisoendial R, Birjmohun R, Keller T, et al. In vivo effects of C-reactive protein (CRP)-infusion into humans. Circ Res. 2005;97:e115–e116

 Funding: This work was in part supported by a grant from Pfizer, which had no involvement in the data analysis/interpretation or writing the manuscript. John J. P. Kastelein is an established investigator of The Netherlands Heart Foundation (2000D039).

 Conflict of Interest: None.

 Authorship: All authors had access to the data and played a role in writing.

PII: S0002-9343(09)00116-8

doi: 10.1016/j.amjmed.2008.11.032

The American Journal of Medicine
Volume 122, Issue 6 , Pages 582.e1-582.e9 , June 2009

Article Tools

* Image Usage & Resolution